Ares Capital Corporation (ARCC) is a business development company. The firm specializes in acquisition, recapitalization, and leveraged buyout transactions of middle market companies. It prefers to make investments in companies engaged in the basic and growth manufacturing, business services, consumer products, health care products and services, and information technology service sectors. The firm will also consider investments in industries such as restaurants, retail, oil and gas, and technology. The firm invests in companies based in North America. It invests in leveraged finance products such as first lien senior debt, second lien senior debt, subordinated debt, and non-control preferred and common equity. Ares Capital Corporation was founded in 2004 and is based in New York, New York with an additional office in Los Angeles, California. The firm operates as a subsidiary of ARES Capital Management LLC.
Camden Partners was founded in 1995 and built on the belief that structural inefficiencies in the public equity markets create significant investment opportunities. More specifically, small-cap stocks often lack research sponsorship and an active following among institutional investors. This often leads to a vicious cycle in which lower valuation is compounded by loss of coverage, block sales, departure of market makers and selling by momentum investors causing further diminution in stock price. To this end, Camden Partners looks to capitalize on the disconnect between business fundamentals and valuation in the small and micro-cap market segments. More specifically, on the private equity side, the firm provides growth capital to micro-cap public, and to a lesser extent, late-stage private companies through direct negotiated and structured transactions. On the hedge fund side, the firm executes a balanced long-short strategy focused on the same niche of the public market, benefiting from the small cap market inefficiencies discussed above.
HLM Venture Partners is a proven, successful venture capital health care investor. Over 60 privately held health care companies have benefited from our expertise, resources and commitment. Emerging health care companies can be confident that HLM Venture Partners’ longevity, integrity and reputation will be invaluable assets as we work together to transform their innovative ideas into market-leading businesses.
Meritech Capital is a leading provider of late-stage venture capital to premier information and medical technology companies. With over $2.2 billion under management, Meritech seeks to lead investments in the portfolio companies of leading early stage venture capital firms. We pursue traditional growth companies as well as co-investments in corporate buy-outs and spin-offs.
New Enterprise Associates (NEA) is a leading venture capital firm focused on helping entrepreneurs create and build major new enterprises that use technology to improve the way we live, work and play. Since its founding in 1978, the firm has followed the same basic principles: support their entrepreneurs, provide an excellent return to their limited partners and practice their profession with high standards and respect. Practicing classic venture capital for over 25 years, NEA focuses on early stage investments, playing an active role in assisting management to build companies of lasting value. With $6 billion under management, NEA's experienced management team has invested in over 500 companies, of which more than 145 have gone public and more than 185 have been acquired. NEA has offices in Menlo Park, California, Reston, Virginia and Baltimore, Maryland.
Salix Ventures manages two venture capital partnerships with approximately $180 million in capital commitments from limited partners. Salix invests primarily in early-stage healthcare services and healthcare information technology companies. With offices in Andover, Nashville and San Francisco, Salix Ventures assists companies across the country through all stages of development.
CCP Equity Partners is a leading private equity firm providing growth capital to innovative financial services and healthcare services companies. In partnership with proven management teams, they shape strategy by leveraging operating skills, deep industry experience and extensive networks to drive value, accelerate growth, and deliver superior returns to our investors. CCP currently manages more than $500 million and offers scalable financial solutions.
Versant Ventures is a leading healthcare-focused venture capital firm specializing in early-stage investments in medical devices, biotechnology and pharmaceuticals, healthcare services, and healthcare information technology. The firm, founded in 1999, consists of a seasoned team of eleven managing directors with more than 115 years of venture capital investing experience and more than 145 years of operating experience.Versant Ventures currently manages over $1 billion in committed capital and has raised its third fund in November 2005. Versant Ventures is currently managing over 70 companies in its portfolio.
